877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Opioids, Monoamine oxidase inhibitors

Categories

Analgesics (5)
Drugs acting on the nervous system (5)
Kappa antagonists (5)
Neuroprotective agents (5)
Opioid antagonists (5)
Opioid receptor ligands (5)
Psychoactive drugs (5)
Food Additives (1)
Pharmaceuticals (1)

Suppliers

Sigma Aldrich (3)
AK Scientific (1)
Frontier Scientific (1)
Matrix Scientific (1)
Oakwood Chemical (1)
TCI Chemicals (1)

Cianidanol (154-23-4, 8001-48-7, 100786-01-4, 7295-85-4)  
Catechin  ·  Epicatechin  ·  Catechuic Acid
Catechin is a flavan-3-ol, a type of natural phenol and antioxidant. It is a plant secondary metabolite. It belongs to the group of flavan-3-ols (or simply flavanols), part of the chemical family of flavonoids.
(-)-Epicatechin (490-46-0)  
Catechin  ·  Epicatechin  ·  Catechuic Acid
Catechin is a flavan-3-ol, a type of natural phenol and antioxidant. It is a plant secondary metabolite. It belongs to the group of flavan-3-ols (or simply flavanols), part of the chemical family of flavonoids.

Related Results:
pargyline (555-57-7)  
Pargyline Hydrochloride
Pargyline (brand name Eutonyl) is an irreversible selective monoamine oxidase (MAO)-B inhibitor drug (IC50 for MAO-A is 0.01152 µmol/L and for MAO-B is 0.00820 µmol/L) It was brought to market in the US and the UK by Abbott in 1963 as an antihypertensive drug branded "Eutonyl". It was one of several MAO inhibitors introduced in the 1960s including nialamide, isocarboxazid, phenelzine, and tranylcypromine. By 2007 the drug was discontinued and as of 2014 there were no generic versions available in the US.
Deprenyl (14611-51-9, 2323-36-6)  
Selegiline, also known as L-deprenyl, is a substituted phenethylamine. At normal clinical doses, it is a selective irreversible MAO-B inhibitor. In larger doses it loses its specificity and also inhibits MAO-A.
4-Methylbenzylamine (104-84-7)  
4-methylbenzylamine hydrochloride
Brofaromine (63638-91-5)  
Brofaromine (proposed brand name Consonar) is a reversible inhibitor of monoamine oxidase A (RIMA) discovered by Ciba-Geigy. The compound was primarily researched in the treatment of depression and anxiety but its development was dropped before it was brought to market. Brofaromine also acts as a serotonin reuptake inhibitor, and its dual pharmacologic effects offered promise in the treatment of a wide spectrum of depressed patients while producing less severe anticholinergic side effects in comparison with older standard drugs like the tricyclic antidepressants.
2-Phenylcyclopropanamine (155-09-9)  
Tranylcypromine (contracted from trans-2-phenylcyclopropylamine; original trade name Parnate) is a monoamine oxidase inhibitor (MAOI); more specifically, tranylcypromaine acts as nonselective and irreversible inhibitor of the enzyme monoamine oxidase (MAO). It is used as an antidepressant and anxiolytic agent in the clinical treatment of mood and anxiety disorders, respectively. Tranylcypromine is a propylamine formed from the cyclization of amphetamine's side chain; therefore, it is classified as a substituted amphetamine.
3,4-Dimethoxybenzylamine (5763-61-1)  
3,4-DBA  ·  3,4-dimethoxybenzylamine monohydrochloride  ·  veratrylamine
Phenelzine (51-71-8)  
Nardil  ·  Phenelzine Sulfate  ·  2 Phenethylhydrazine
Phenelzine (Nardil, Nardelzine) is a non-selective and irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class which is used as an antidepressant and anxiolytic. Along with tranylcypromine and isocarboxazid, phenelzine is one of the few non-selective and irreversible MAOIs still in widespread clinical use. It is typically available in 15 mg tablets and doses usually range from 30–90 mg per day, with 15 mg every day or every other day suggested as a maintenance dose following a successful course of treatment.
Benzylamine hydrochloride (3287-99-8)  
benzylamine  ·  benzylamine hydrobromide  ·  benzylamine monosulfate
Nisoxetine (53179-07-0, 57754-86-6, 57226-61-6)  
3-(o-methoxyphenoxy)-N-methyl-3-phenylpropylamine  ·  LY 135252  ·  N-methyl-gamma-(2-methylphenoxy)phenylpropanolamine
Nisoxetine, originally synthesized in the Lilly research laboratories during the early 1970s, is a potent and selective inhibitor for the reuptake of norepinephrine (noradrenaline) into synapses. It currently has no clinical applications in humans, although it was originally researched as an antidepressant. Nisoxetine is now widely used in scientific research as a standard selective norepinephrine reuptake inhibitor.
Lazabemide (103878-84-8)  
Lazabemide (proposed trade names Pakio, Tempium) is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) that was under development as an antiparkinsonian agent but was never marketed.
6-methyltetrahydropterin (942-41-6)  
6-methyl-5,6,7,8-tetrahydropteridine  ·  2-amino-6-methyl-5,6,7,8-tetrahydro-4(3H)-pteridinone  ·  6-methyltetrahydropteridine
Related searches
Opioids
Monoamine oxidase inhibitors
Next Page >